Tandem Diabetes Care, Inc. (TNDM): Price and Financial Metrics
TNDM Price/Volume Stats
| Current price | $30.35 | 52-week high | $40.92 |
| Prev. close | $30.93 | 52-week low | $13.82 |
| Day low | $30.27 | Volume | 562,820 |
| Day high | $31.39 | Avg. volume | 1,736,662 |
| 50-day MA | $29.67 | Dividend yield | N/A |
| 200-day MA | $25.60 | Market Cap | 1.96B |
TNDM Stock Price Chart Interactive Chart >
Tandem Diabetes Care, Inc. (TNDM) Company Bio
Tandem Diabetes Care, Inc. focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. The company was founded in 2006 and is based in San Diego, California.
Latest TNDM News From Around the Web
Below are the latest news stories about TANDEM DIABETES CARE INC that investors may wish to consider to help them evaluate TNDM as an investment opportunity.
DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin PumpDexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring. |
Here's Why You Should Retain Tandem Diabetes (TNDM) NowInvestors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions. |
Tandem Diabetes (TNDM) Avails Tandem Source in the United StatesTandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers. |
Tandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare ProvidersSAN DIEGO, December 12, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the launch of Tandem Source, a diabetes management platform for insulin pump users and healthcare providers (HCPs). Tandem Source is designed to bring together the features of Tandem’s legacy t:connect, t:connect HCP, and t:connect Portal offerings with new comprehensive data reporting in one central, scalable platform. Tandem Source is now availabl |
Tandem Diabetes (TNDM) Launches Dexcom G7 Integrated t:slim X2Tandem Diabetes' (TNDM) t:slim X2 is the first AID system in the world to feature Dexcom's most advanced CGM technology. |
TNDM Price Returns
| 1-mo | -6.50% |
| 3-mo | 22.63% |
| 6-mo | 57.09% |
| 1-year | -22.22% |
| 3-year | -67.34% |
| 5-year | -44.22% |
| YTD | 2.60% |
| 2023 | -34.19% |
| 2022 | -70.14% |
| 2021 | 57.32% |
| 2020 | 60.51% |
| 2019 | 56.99% |
Continue Researching TNDM
Here are a few links from around the web to help you further your research on Tandem Diabetes Care Inc's stock as an investment opportunity:Tandem Diabetes Care Inc (TNDM) Stock Price | Nasdaq
Tandem Diabetes Care Inc (TNDM) Stock Quote, History and News - Yahoo Finance
Tandem Diabetes Care Inc (TNDM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...